DD102148A5 - - Google Patents

Info

Publication number
DD102148A5
DD102148A5 DD165084A DD16508472A DD102148A5 DD 102148 A5 DD102148 A5 DD 102148A5 DD 165084 A DD165084 A DD 165084A DD 16508472 A DD16508472 A DD 16508472A DD 102148 A5 DD102148 A5 DD 102148A5
Authority
DD
German Democratic Republic
Application number
DD165084A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD102148A5 publication Critical patent/DD102148A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DD165084A 1971-09-01 1972-08-16 DD102148A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2143745A DE2143745A1 (de) 1971-09-01 1971-09-01 3,4-dihydro-2h-isochinolin-1-thione und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD102148A5 true DD102148A5 (fr) 1973-12-05

Family

ID=5818354

Family Applications (1)

Application Number Title Priority Date Filing Date
DD165084A DD102148A5 (fr) 1971-09-01 1972-08-16

Country Status (11)

Country Link
JP (1) JPS4834885A (fr)
AU (1) AU4610472A (fr)
BE (1) BE788321A (fr)
CA (1) CA972755A (fr)
DD (1) DD102148A5 (fr)
DE (1) DE2143745A1 (fr)
ES (1) ES406134A1 (fr)
FR (1) FR2151044A1 (fr)
IL (1) IL40250A0 (fr)
NL (1) NL7211627A (fr)
ZA (1) ZA725997B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89997A0 (en) * 1988-04-25 1989-12-15 Lilly Co Eli Propanamine derivatives
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
ES2067508T3 (es) * 1988-08-19 1995-04-01 Warner Lambert Co Dihidroisoquinolinonas sustituidas y compuestos relacionados como potenciadores de los efectos letales de la radiacion y de ciertos agentes quimioterapeuticos; compuestos seleccionados, analogos y proceso.
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
WO2002090334A1 (fr) * 2001-05-08 2002-11-14 Kudos Pharmaceuticals Limited Derives d'isoquinolinone comme inhibiteurs de parp
US7196085B2 (en) 2002-04-30 2007-03-27 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
RU2010108008A (ru) 2007-09-14 2011-10-20 Астразенека Аб (Se) Фталазиноновые производные
US8183369B2 (en) 2007-10-17 2012-05-22 Kudos Pharmaceuticals Limited 4- [3- (4-cyclopropanecarbonyl-piperazine-I-carbonyl) -4 -fluoro-benzyl] -2H-phthalaz in-1-one
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
CN102238945B (zh) 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514

Also Published As

Publication number Publication date
DE2143745A1 (de) 1973-03-08
NL7211627A (fr) 1973-03-05
CA972755A (en) 1975-08-12
ES406134A1 (es) 1975-08-01
ZA725997B (en) 1973-07-25
BE788321A (fr) 1973-03-01
JPS4834885A (fr) 1973-05-22
FR2151044A1 (en) 1973-04-13
IL40250A0 (en) 1972-10-29
AU4610472A (en) 1974-03-07

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AR196074A1 (fr)
FR2147164B1 (fr)
AU2691671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU3005371A (fr)
AU2894671A (fr)
AU2742671A (fr)
AR202997Q (fr)
AU2875571A (fr)
AU2837671A (fr)
AU2724971A (fr)
AU2726271A (fr)
AU2740271A (fr)
AU2940971A (fr)
AU2755871A (fr)
AU2836771A (fr)
AU2880771A (fr)
AU2885171A (fr)
AU2706571A (fr)
AU2907471A (fr)
AU2927871A (fr)
AU2854371A (fr)
AU2930871A (fr)